glp-1 and type 2 diabetes GLP-1: Actions on Beta-cell Mass Function GLP-1 trends 2025: real-world data,

While growth hormone can influence fat metabolism and muscle mass, clinical research on Sermorelin has primarily focused on treating growth hormone deficiency and anti-aging, rather than weight loss

Mol Metab 2014;3:507-17.ArticlePubMedPMC 23

Vildagliptin stimulates endothelial cell network formation and ischemia-induced revascularization via an endothelial nitric-oxide synthase-dependent mechanism

Nausea from GLP-1 medications is often treatable and manageable with the right strategies

However, the pharmacodynamics of GLP-1RAs reveal additional complexity

Jandee S, Geeraerts A, Geysen H, Rommel N, Tack J, Vanuytsel T